Bosh sahifaOCEAW • OTCMKTS
add
Ocean Biomedical
Yopilish kursi
0,0070 $
Yillik diapazon
0,0025 $ - 0,18 $
Bozor kapitalizatsiyasi
1,04 mln USD
Oʻrtacha hajm
25,06 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Daromad | — | — |
Joriy xarajat | 958,00 ming | 61,01% |
Sof foyda | -8,24 mln | -163,39% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | — | — |
Jami aktivlari | 1,58 mln | -46,30% |
Jami passivlari | 93,98 mln | 19,37% |
Umumiy kapital | -92,40 mln | — |
Tarqatilgan aksiyalar | 91,02 mln | — |
Narxi/balansdagi bahosi | -0,01 | — |
Aktivlardan daromad | -192,83% | — |
Kapitaldan daromad | 3,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Sof foyda | -8,24 mln | -163,39% |
Operatsiyalardan naqd pul | -356,00 ming | 26,60% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 909,00 ming | — |
Naqd pulning sof oʻzgarishi | 553,00 ming | 214,02% |
Boʻsh pul | -1,82 mln | -159,87% |
Haqida
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Tashkil etilgan
2019
Xodimlar soni
7